104 related articles for article (PubMed ID: 31004283)
21. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
[TBL] [Abstract][Full Text] [Related]
22. B-type natriuretic peptide vs. cardiac risk scores for prediction of outcome following major orthopedic surgery.
Katsanos S; Babalis D; Kafkas N; Mavrogenis A; Leong D; Parissis J; Varounis C; Makris K; van der Heijden A; Anastasiou-Nana M; Filippatos G
J Cardiovasc Med (Hagerstown); 2015 Jun; 16(6):465-71. PubMed ID: 25469732
[TBL] [Abstract][Full Text] [Related]
23. Brain natriuretic peptide as a risk marker for incident hypertensive cardiovascular events.
Suzuki M; Hamada M; Yamamoto K; Kazatani Y; Hiwada K
Hypertens Res; 2002 Sep; 25(5):669-76. PubMed ID: 12452317
[TBL] [Abstract][Full Text] [Related]
24. N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study.
März W; Tiran B; Seelhorst U; Wellnitz B; Bauersachs J; Winkelmann BR; Boehm BO;
Clin Chem; 2007 Jun; 53(6):1075-83. PubMed ID: 17446333
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Significance of Asymptomatic Brain Natriuretic Peptide Elevation at Nephrology Referral in Patients with Chronic Kidney Disease.
Hayashi T; Yasuda K; Kimura T; Sasaki K; Shimada K; Hashimoto N; Isaka Y
Am J Nephrol; 2018; 48(3):205-213. PubMed ID: 30196305
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of B-type natriuretic peptide and its amino-terminal proBNP fragment for cardiovascular events with stratification by renal function.
Horii M; Matsumoto T; Uemura S; Sugawara Y; Takitsume A; Ueda T; Nakagawa H; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Takeda Y; Kawata H; Kawakami R; Saito Y
J Cardiol; 2013 Jun; 61(6):410-6. PubMed ID: 23618914
[TBL] [Abstract][Full Text] [Related]
27. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
[TBL] [Abstract][Full Text] [Related]
28. A frailty index based on laboratory deficits in community-dwelling men predicted their risk of adverse health outcomes.
Blodgett JM; Theou O; Howlett SE; Wu FC; Rockwood K
Age Ageing; 2016 Jul; 45(4):463-8. PubMed ID: 27076524
[TBL] [Abstract][Full Text] [Related]
29. B-Type Natriuretic Peptide and Cardiac Troponin I Are Associated With Adverse Outcomes in Stable Kidney Transplant Recipients.
Jarolim P; Claggett BL; Conrad MJ; Carpenter MA; Ivanova A; Bostom AG; Kusek JW; Hunsicker LG; Jacques PF; Gravens-Mueller L; Finn P; Solomon SD; Weiner DE; Levey AS; Pfeffer MA
Transplantation; 2017 Jan; 101(1):182-190. PubMed ID: 26910333
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal assessment of N-terminal pro-B-type natriuretic peptide and risk of diabetes in older adults: The cardiovascular health study.
Brutsaert EF; Biggs ML; Delaney JA; Djoussé L; Gottdiener JS; Ix JH; Kim F; Mukamal KJ; Siscovick DS; Tracy RP; de Boer IH; deFilippi CR; Kizer JR
Metabolism; 2016 Oct; 65(10):1489-97. PubMed ID: 27621184
[TBL] [Abstract][Full Text] [Related]
31. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
[TBL] [Abstract][Full Text] [Related]
32. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.
Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Bickel C; Lackner KJ; Cambien F; Tiret L; Münzel T; Blankenberg S
J Am Coll Cardiol; 2006 Feb; 47(3):552-8. PubMed ID: 16458135
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis.
Ryding AD; Kumar S; Worthington AM; Burgess D
Anesthesiology; 2009 Aug; 111(2):311-9. PubMed ID: 19602961
[TBL] [Abstract][Full Text] [Related]
34. Plasma B-type natriuretic peptide level and cardiovascular events in chronic kidney disease in a community-based population.
Sakuma M; Nakamura M; Tanaka F; Onoda T; Itai K; Tanno K; Ohsawa M; Sakata K; Yoshida Y; Kawamura K; Makita S; Okayama A
Circ J; 2010 Apr; 74(4):792-7. PubMed ID: 20160392
[TBL] [Abstract][Full Text] [Related]
35. Brain natriuretic peptide is related to carotid plaques and predicts atherosclerosis in pre-dialysis patients with chronic kidney disease.
Zhou W; Ni Z; Yu Z; Shi B; Wang Q
Eur J Intern Med; 2012 Sep; 23(6):539-44. PubMed ID: 22863432
[TBL] [Abstract][Full Text] [Related]
36. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure.
McKie PM; Rodeheffer RJ; Cataliotti A; Martin FL; Urban LH; Mahoney DW; Jacobsen SJ; Redfield MM; Burnett JC
Hypertension; 2006 May; 47(5):874-80. PubMed ID: 16585413
[TBL] [Abstract][Full Text] [Related]
37. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
[TBL] [Abstract][Full Text] [Related]
39. Clinical implications of B-type natriuretic peptide and N-terminal pro--B-type natriuretic peptide in the care of the vascular surgery patient.
Wayne Causey M; Singh N
Semin Vasc Surg; 2014 Dec; 27(3-4):143-7. PubMed ID: 26073822
[TBL] [Abstract][Full Text] [Related]
40. B-Type Natriuretic Peptide and Ventricular Dysfunction in the Prediction of Cardiovascular Events and Death in Hypertension.
Gallagher J; Watson C; Zhou S; Ryan F; Ledwidge M; McDonald K
Am J Hypertens; 2018 Jan; 31(2):228-234. PubMed ID: 29036547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
